Telenursing Interventions for Patients With Cancer Receiving Chemotherapy: A Scoping Review

Aurora De Leo

Gloria Liquori

Sara Dionisi

Fabrizio Petrone

Alessandro Spano

Nicolò Panattoni

Noemi Giannetta

Marco Di Muzio

Emanuele Di Simone

telenursing, chemotherapy, adverse events, oncology nursing, cancer
ONF 2023, 50(6), 767-782. DOI: 10.1188/23.ONF.767-782

Problem Identification: To provide an overview of telenursing interventions, primary outcomes, and tools used in patients with cancer receiving chemotherapy, a scoping review was conducted.

Literature Search: PubMed®, Embase®, and CINAHL® databases were searched using the following keywords: telenursing, adverse event, and drug therapy.

Data Evaluation: From the screening process, 11 studies were identified.

Synthesis: In patients with cancer receiving chemotherapy, telenursing interventions were mainly used to monitor symptoms, particularly fatigue, anxiety, and depression. The interventions used included outcome-specific, nonspecific, and validated tools, or tools developed from reporting systems for adverse events.

Implications for Research: Large-scale, well-conducted randomized controlled trials, systematic reviews, and meta-analyses are needed to test the results of this scoping review.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.